Literature DB >> 22936665

HIF-1α is a negative regulator of plasmacytoid DC development in vitro and in vivo.

Andreas Weigert1, Benjamin Weichand, Divya Sekar, Weixiao Sha, Christina Hahn, Javier Mora, Stephanie Ley, Silke Essler, Nathalie Dehne, Bernhard Brüne.   

Abstract

Hypoxia-inducible factors (HIFs) regulate hematopoiesis in the embryo and maintain hematopoietic stem cell function in the adult. How hypoxia and HIFs contribute to hematopoietic lineage differentiation in the adult is ill defined. Here we provide evidence that HIF-1 limits differentiation of precursors into plasmacytoid dendritic cells (pDCs). Low oxygen up-regulated inhibitor of DNA binding 2 (ID2) and suppressed Flt3-L-induced differentiation of bone marrow cells to pDCs in wild-type but not HIF-1α(fl/fl) LysM-Cre bone marrow cells. Moreover, pDC differentiated normally in hypoxic ID2(-/-) bone marrow cultures. Finally, we observed elevated pDC frequencies in bone marrow, blood, and spleen of HIF-1α(fl/fl) LysM-Cre and ID2(-/-), but not HIF-2α(fl/fl) LysM-Cre mice. Our data indicate that the low oxygen content in the bone marrow might limit pDC development. This might be an environmental mechanism to restrict the numbers of these potentially autoreactive cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22936665     DOI: 10.1182/blood-2012-03-417022

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

1.  Myeloid Cell-Derived HIF-1α Promotes Control of Leishmania major.

Authors:  Valentin Schatz; Yannic Strüssmann; Alexander Mahnke; Gunnar Schley; Maximilian Waldner; Uwe Ritter; Jens Wild; Carsten Willam; Nathalie Dehne; Bernhard Brüne; Jennifer M McNiff; Oscar R Colegio; Christian Bogdan; Jonathan Jantsch
Journal:  J Immunol       Date:  2016-10-17       Impact factor: 5.422

Review 2.  The multifaceted biology of plasmacytoid dendritic cells.

Authors:  Melissa Swiecki; Marco Colonna
Journal:  Nat Rev Immunol       Date:  2015-07-10       Impact factor: 53.106

3.  ID2 and HIF-1α collaborate to protect quiescent hematopoietic stem cells from activation, differentiation, and exhaustion.

Authors:  Brad L Jakubison; Tanmoy Sarkar; Kristbjorn O Gudmundsson; Shweta Singh; Lei Sun; Holly M Morris; Kimberly D Klarmann; Jonathan R Keller
Journal:  J Clin Invest       Date:  2022-07-01       Impact factor: 19.456

4.  Clonal lineage tracing reveals shared origin of conventional and plasmacytoid dendritic cells.

Authors:  Jue Feng; Joseph N Pucella; Geunhyo Jang; Marcela Alcántara-Hernández; Samik Upadhaya; Nicholas M Adams; Alireza Khodadadi-Jamayran; Colleen M Lau; Marlon Stoeckius; Stephanie Hao; Peter Smibert; Aristotelis Tsirigos; Juliana Idoyaga; Boris Reizis
Journal:  Immunity       Date:  2022-02-17       Impact factor: 43.474

5.  IRF-5-Mediated Inflammation Limits CD8+ T Cell Expansion by Inducing HIF-1α and Impairing Dendritic Cell Functions during Leishmania Infection.

Authors:  Akil Hammami; Tania Charpentier; Mélina Smans; Simona Stäger
Journal:  PLoS Pathog       Date:  2015-06-05       Impact factor: 6.823

Review 6.  The role of dendritic cells in graft-versus-tumor effect.

Authors:  Tomomi Toubai; Nathan Mathewson; Pavan Reddy
Journal:  Front Immunol       Date:  2014-02-21       Impact factor: 7.561

Review 7.  Hypoxia-Inducible Factor (HIF) as a Pharmacological Target for Prevention and Treatment of Infectious Diseases.

Authors:  Tamara Bhandari; Victor Nizet
Journal:  Infect Dis Ther       Date:  2014-06-24

Review 8.  Dendritic Cells under Hypoxia: How Oxygen Shortage Affects the Linkage between Innate and Adaptive Immunity.

Authors:  Sandra Winning; Joachim Fandrey
Journal:  J Immunol Res       Date:  2016-02-04       Impact factor: 4.818

Review 9.  Beyond Immune Cell Migration: The Emerging Role of the Sphingosine-1-phosphate Receptor S1PR4 as a Modulator of Innate Immune Cell Activation.

Authors:  Catherine Olesch; Christian Ringel; Bernhard Brüne; Andreas Weigert
Journal:  Mediators Inflamm       Date:  2017-08-07       Impact factor: 4.711

Review 10.  Trial watch: Dendritic cell-based interventions for cancer therapy.

Authors:  Erika Vacchelli; Ilio Vitale; Alexander Eggermont; Wolf Hervé Fridman; Jitka Fučíková; Isabelle Cremer; Jérôme Galon; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2013-07-29       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.